Hip fracture surgery timing and blood transfusion risk on DOACs
Part of Blood & lymphatic, Immune system & allergy, Injuries & trauma clinical trials.
This study looks at whether the timing of hip fracture surgery affects the need for blood transfusions in patients taking blood thinners (DOACs). It might help guide better care for people on these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a broken hip that needs surgery.
- You are taking a blood thinner (DOAC) and took your last dose within 24 hours before arriving at the emergency room.
- Your fracture is not from cancer or a prior hip replacement.
- Your fracture happened within the past 24 hours before you came to the ER.
- You do not have a blood disorder like sickle cell disease or leukemia.
- You are not taking betrixaban (a blood thinner not approved in Europe).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients taking certain blood-thinning medications (DOACs) have more bleeding during oral biopsies—small tissue samples taken from the mouth. Understanding this helps doctors know how to safely care for patients on these medications.
This Phase 3 trial studies when it is safest to restart a common blood thinner (a DOAC) after a traumatic brain bleed. It may help reduce stroke or clot risk while lowering the chance of another bleeding episode.
This study looks at how bleeding after a hip fracture might affect confusion (delirium) in older adults. It will help doctors understand how to better manage bleeding to prevent confusion.
This study compares whether you should temporarily stop your blood thinner (DOAC) or keep taking it when you have an elective heart catheter test or procedure (coronary angiography or PCI). It aims to see which approach is safer and better for preventing bleeding and clotting around the procedure.
This study looks at whether fixing a hip fracture sooner is better for people who take a direct oral anticoagulant (DOAC) blood thinner. It compares early surgery versus delayed surgery in people whose delay is specifically from the blood thinner.
This trial looks at patients with a broken hip who take a type of blood thinner called a NOAC. It measures bleeding during surgery to fix the hip, without stopping or delaying the surgery. The goal is to see if it is safe to operate right away.
Hear when a new Blood Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.